Pfizer is suing Johnson & Johnson, saying it prevented uptake of cheaper Remicade rival
September 20, 2017 at 11:55 AM EDT
In an antitrust lawsuit, Pfizer alleged that Johnson & Johnson contracts prevented sales of Pfizer’s Inflectra.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|